Home > Insider Trading > Filing (0001127602-13-021360)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1145197	Insulet Corp	PODD	Surgical & Medical Instruments & Apparatus (3841)	043523891

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1199735	Sally Crawford	C/O Insulet Corporation 9 Oak Park Drive Bedford MA 01730		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-06-14	3,000	$14.48	19,000	No	4	M	Direct
Common Stock	Acquisiton	2013-06-14	18,480	$7.06	37,480	No	4	M	Direct
Common Stock	Acquisiton	2013-06-14	9,520	$5.50	47,000	No	4	M	Direct
Common Stock	Disposition	2013-06-14	31,000	$30.47	16,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2013-06-14	3,000	$0.00	3,000	$14.48
Common Stock	Stock Option (Right to Buy)	Disposition	2013-06-14	18,480	$0.00	18,480	$7.06
Common Stock	Stock Option (Right to Buy)	Disposition	2013-06-14	9,520	$0.00	9,520	$5.50

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,000	2020-06-01	No	4	M	Direct
0	2019-07-30	No	4	M	Direct
0	2018-10-29	No	4	M	Direct

Footnotes

Includes 1,000 restricted stock units granted on May 12, 2011 which fully vest on April 30, 2014; 2,000 restricted stock units granted on June 1, 2012 which vest 50% of the total units on April 30, 2014 and 50% of the total units on April 30, 2015; and 4,000 restricted stock units granted on June 3, 2013 which vest 50% of the total units on April 30, 2014, 25% of the total units on April 30, 2015 and 25% of the total units on April 30, 2016, subject to continued service as a director or consultant. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2013.
The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $30.37 to $30.74. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full informaiton regarding the number of shares sold at each separate price.
This option is subject to a three-year vesting period with 50% of the total award vesting on the first anniversary of the date of grant and 25% on each of the second and third anniversaries of the date of grant, subject to continued service as a director or consultant.